Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 153
4.
Dis Colon Rectum ; 63(9): 1225-1233, 2020 09.
Article En | MEDLINE | ID: mdl-33216493

BACKGROUND: Pelvic exenteration for malignancy sometimes necessitates flap reconstruction. OBJECTIVE: This study's aim was to investigate flap-related morbidity. DESIGN: A prospective database was reviewed from 2003 to 2016. All medical charts, correspondence, and outpatient follow-up records up to May 2017 were reviewed. SETTINGS: This study was conducted at a tertiary referral unit. PATIENTS: Patients who underwent pelvic exenteration surgery were selected. INTERVENTIONS: Reconstruction was performed with a vertical rectus abdominis myocutaneous flap. MAIN OUTCOME MEASURES: Primary outcome was flap-related complications (short or long term >3 months). Secondary outcomes were hospital stay, readmission, mortality, and quality of life (Short Form-36, Functional Assessment of Cancer Therapy for patients with colorectal cancer). RESULTS: Of 519 patients undergoing pelvic exenteration surgery, 87 (17%) underwent flap reconstruction. Median follow-up was 20 months (interquartile range, 8-39 months). Median age was 60 years (interquartile range, 51-66). Flap-related complications were found in 59 patients (68%), with minor recipient-site complications diagnosed in 33 patients (38%). In the short term, 15 patients experienced major recipient-site complications (17%), including flap separation (n = 7) and partial (n = 3) or complete necrosis (n = 4). Flap removal was required in 1 patient. Obesity was the single independent risk factor for short-term flap-related complications (p = 0.02). Hospital admission was significantly longer in patients with short-term major flap complications (median 65 days, p < 0.001) compared with patients without or with minor complications. There was no 90-day mortality. Patients who required flap reconstruction reported lower baseline quality-of-life scores than patients without flap reconstruction, but both recovered over time. In the long term, minor flap-related complications occurred in 12 patients, and 11 patients had major donor-site complications. Fourteen patients developed major recipient-site complications (16%), including sacral collections, enterocutaneous fistulas, perineal ulcer, or hernia. LIMITATIONS: This was a retrospective analysis of prospectively collected data. CONCLUSIONS: Vertical rectus abdominis myocutaneous flaps in pelvic exenteration surgery have a high incidence of morbidity that has significant impact on hospital stay and a temporary impact on quality of life. Flap reconstruction should be used selectively in pelvic exenteration surgery. See Video Abstract at http://links.lww.com/DCR/B274. COMPLICACIONES E IMPACTO EN LA CALIDAD DE VIDA DE LOS COLGAJOS MIOCUTÁNEOS DE MUSCULO RECTO DEL ABDOMEN EN CASOS DE RECONSTRUCCIÓN DE EXENTERACIÓN PÉLVICA: La exenteración pélvica (EP) para malignidad a veces requiere reconstrucción con colgajos musculares.El propósito del presente estudio fue investigar la morbilidad relacionada con los colagajos musculares.Revisión de una base de datos prospectiva de 2003-2016. Se evaluaron todas las historias clínicas, la correspondencia y los registros de seguimiento de pacientes ambulatorios hasta mayo de 2017.Unidad de referencia terciaria.Todos aquellas personas con cirugía de exenteración pélvica.Reconstrucción con colgajo miocutáneo de musculo recto vertical del abdomen.El resultado primario fueron las complicaciones relacionadas con el colgajo (a corto o largo plazo >3 meses). Los resultados secundarios fueron la estadía hospitalaria, la readmisión, la mortalidad y la calidad de vida (QOL; SF-36, FACT-C).De 519 pacientes sometidos a EP, 87 (17%) se sometieron a reconstrucción con colgajos miocutáneos. La mediana de seguimiento fue de 20 meses (RIC 8-39 meses). La mediana de edad fue de 60 años (IQR 51-66). Se encontraron complicaciones relacionadas con el colgajo en 59 pacientes (68%), con complicaciones menores en el sitio del receptor diagnosticadas en 33 pacientes (38%). A corto plazo, quince pacientes sufrieron complicaciones mayores en el sitio del receptor (17%), incluida la separación del colgajo (n = 7), necrosis parcial (n = 3) o necrosis completa (n = 4). Se requirió la extracción del colgajo en un paciente. La obesidad fue el único factor de riesgo independiente para complicaciones relacionadas con el colgajo a corto plazo (p = 0.02). El ingreso hospitalario fue significativamente mayor en pacientes con complicaciones de colgajos mayores a corto plazo (mediana 65 días p <0.001) en comparación con pacientes sin complicaciones menores o con complicaciones menores. No hubo mortalidad a los 90 días. Los pacientes que requirieron reconstrucción con colgajo informaron puntajes de calidad de vida basales más bajos que los pacientes sin reconstrucción con colgajo, pero ambos se recuperaron con el tiempo. A largo plazo, ocurrieron complicaciones menores relacionadas con el colgajo en 12 pacientes y 11 pacientes tuvieron complicaciones mayores en el sitio donante. Catorce pacientes desarrollaron complicaciones mayores en el sitio del receptor (16%), incluidas colecciones sacras, fístulas enterocutáneas, úlceras perineales o herniación.Análisis retrospectivo de datos recolectados prospectivamente.Los colgajos miocutáneos del musculo recto vertical del abdomen en casos de cirugía de exenteración pélvica tienen una alta incidencia de morbilidad conllevando a un impacto significativo en la estadía hospitalaria y un impacto temporal en la calidad de vida. Las reconstrucciones con colgajos deben aplicarse muy selectivamente en la cirugía de exenteración pélvica. Consulte Video Resumen en http://links.lww.com/DCR/B274.


Incisional Hernia/epidemiology , Intestinal Fistula/epidemiology , Myocutaneous Flap/transplantation , Pelvic Exenteration/methods , Plastic Surgery Procedures/methods , Postoperative Complications/epidemiology , Quality of Life , Rectus Abdominis/transplantation , Adenocarcinoma , Aged , Carcinoma, Squamous Cell , Female , Humans , Incisional Hernia/physiopathology , Incisional Hernia/psychology , Intestinal Fistula/physiopathology , Intestinal Fistula/psychology , Length of Stay , Male , Middle Aged , Mortality , Necrosis , Neoadjuvant Therapy/statistics & numerical data , Neoplasm Recurrence, Local , Obesity/epidemiology , Patient Readmission , Perineum , Postoperative Complications/physiopathology , Postoperative Complications/psychology , Rectal Neoplasms , Retrospective Studies , Risk Factors , Surgical Wound Dehiscence/epidemiology , Surgical Wound Dehiscence/physiopathology , Surgical Wound Dehiscence/psychology , Ulcer/epidemiology , Ulcer/physiopathology , Ulcer/psychology , Vagina/surgery
5.
Clin Nutr ; 39(12): 3695-3702, 2020 12.
Article En | MEDLINE | ID: mdl-32331856

BACKGROUND & AIMS: High output entero-cutaneous fistulas may lead to intestinal failure with parenteral nutrition (PN) as the gold standard treatment to prevent dehydration and malnutrition. However in case of entero-atmospheric fistula (EAF) with the distal limb of the fistula accessible, chyme reinfusion (CR), a technique that restores artificially digestive continuity can be performed until the surgical repair. Our aim was to study the efficacy of CR in EAF regarding nutritional status, intestinal function, PN weaning and liver tests. METHODS: Retrospective study of 37 patients admitted for EAF and treated by CR from 1993 to 2017. Delays were expressed in median (25%-75% quartiles) and other data on mean ± SD. RESULTS: Location of EAF: jejunum (29), ileum (8). The length of the upstream intestine was estimated in 21 patients: 19 had a bowel length <150 cm of which 16 had less than 100 cm. During CR, mean digestive losses decreased from 1734 ± 578 to 443 ± 487 ml/24 h (p < 0.000001), nitrogen absorption increased from 45.3 ± 18.6 to 81.8 ± 12.9% of ingesta (p < 0.001). The percentage of patients with plasma citrulline <20 µmol/l decreased from 71 to 10%. PN was stopped in all patients within 3 (0-14) days after CR initiation, 2 patients required an intravenous hydration and 20 had an additional enteral support. The nutritional status improved: albumin (33.1 ± 5.1 g/L vs 28.4 ± 6.5, p < 0.001), NRI (decrease of the number of patients at risk of severe malnutrition from 22 to 10 (p < 0.001)). The number of patients who had one or several liver tests abnormalities (>2 N) decreased from 94 to 41% (p < 0.001). CONCLUSION: When the efferent part of the small bowel is accessible, CR is a safe and inexpensive method that restores bowel function. In most cases, it makes it possible to stop PN and helps to improve the nutritional status until surgical reconstruction.


Gastrointestinal Contents , Infusions, Parenteral/methods , Intestinal Fistula/therapy , Parenteral Nutrition/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Intestinal Fistula/physiopathology , Intestine, Small/physiopathology , Male , Middle Aged , Nutritional Status , Retrospective Studies , Treatment Outcome
6.
Wound Manag Prev ; 66(4): 26-37, 2020 04.
Article En | MEDLINE | ID: mdl-32294057

Enterocutaneous (ECF) and enteroatmospheric (EAF) fistulas are associated with considerable morbidity and patient care challenges, including optimal topical management. PURPOSE: A systematic literature review was conducted to identify topical management interventions used in ECF/EAF care and to explore the role of these interventions in fistula closure and long-term fistula management. METHODS: A search of PubMed, the Cumulative Index of Nursing and Allied Health Literature, and Scopus was conducted to identify English-language articles published from January 2004 to January 2019. The keywords enterocutaneous fistula, enteroatmospheric fistula, negative pressure wound therapy, NPWT, vacuum-assisted closure, VAC, pouch or pouching, troughing, bridging, collection device, dressing, and wound care were used to identify all publications pertaining to the topical management of adult and mixed adult/pediatric patients with an ECF or EAF. Single-person case studies, exclusively pediatric studies, surgical treatment-based, and duplicate publications were excluded. Abstracts were screened for relevance to the research questions, and eligible publications were abstracted and categorized using The Oxford Centre for Evidence-Based Medicine Levels of Evidence. The Joanna Briggs Institute (JBI) critical appraisal checklist for case series was used to assess each article for risk of bias and methodological quality. Outcomes of interest included patient demographics, closure rates, fistula classification (type of fistula, fistula output, fistula origin), type of topical treatment, adverse events (pain, new fistula formation, fistula recurrence, mortality), follow-up, long-term management, perifistula skin protection, effluent management, dressing change frequency, and quality of life. Descriptive statistics were presented; no statistical analysis was performed. RESULTS: Of the 983 articles identified, 57 underwent critical appraisal using the JBI checklist for case series. Forty-two (42) did not meet the inclusion criteria, leaving 15, level IV, case-based publications (N = 410 patients). No randomized controlled trials were found. All studies included some form of negative pressure wound therapy. JBI results found that each study was at high risk of bias in more than 2 domains. Interventions were categorized as intubation, occlusion, or isolation of the fistula. Of the 559 fistulas treated, spontaneous closure was reported in 164 cases, with rates ranging from 0% to 100%. Adverse events to treatment included pain (n = 33 patients), new fistula formation (n = 12), and fistula recurrence (n = 1). Sepsis was the leading cause of mortality (n = 29), with reported rates ranging from 0% to 44%. CONCLUSION: Due to the high risk of study bias and low quality of evidence, the exact contribution of any one intervention could not be established. Results also suggest a high risk of publication bias, and patient-centered outcomes were reported in only 1 study. Although topical management might play a role in fistula closure, it is only as part of a comprehensive plan of care. Future research should focus on developing and using standardized reporting tools, classifications, and outcomes and include patient-centered outcomes such as acceptance, tolerability, pain, and quality of life relating to any one intervention. At this time, the evidence base for management recommendations is limited, suggesting that interventions should mainly be based on practical considerations such as resources and clinician skill.


Administration, Topical , Fistula/drug therapy , Intestinal Fistula/drug therapy , Fistula/physiopathology , Humans , Intestinal Fistula/physiopathology , Quality of Life , Wound Healing/drug effects
7.
Ann Vasc Surg ; 63: 455.e17-455.e21, 2020 Feb.
Article En | MEDLINE | ID: mdl-31622766

Aortoenteric fistula (AEF) is a rare cause of gastrointestinal (GI) bleeding. If not promptly diagnosed and treated, the associated mortality is very high. The role of endovascular treatment is not yet defined. In this article, we report a clinical case of a 94-year-old male patient admitted in the emergency department with rectal bleeding. Owing to the detection of a pulsatile abdominal mass, a computed tomography angiography (CTA) scan was performed, which established the diagnosis of aorto-enteric fistula due to a left common iliac artery aneurysm (CIAA) ruptured to the sigmoid colon and also revealed an abdominal aortic aneurysm (AAA) and an internal iliac artery aneurysm (IIAA). Given the age of the patient, general condition and technical difficulty inherent to the treatment of the IIAA by conventional surgery, we chose endovascular treatment. However, we wanted to avoid contact between the endograft and the colon orifice because of the risk of infection. The patient was treated emergently with an aorto-right uni-iliac graft and a femoro-femoral bypass, IIAA embolization and 2 left iliac excluders (at the origin of the common iliac and distally in the external iliac artery). It was decided to treat colon lesion conservatively. In this case, the aorto-uni-iliac graft excluded the aortic inline flow, the distal occluder prevented retrograde flow from the external iliac, and the embolization prevented retrograde flow and treated the IIAA. This way, no arterial pressure and no prosthetic material existed inside the ruptured artery, hopefully allowing the spontaneous closing of the orifice leading the sigmoid colon to heal. The postoperative period was uneventful, and the patient was discharged at the 8th postoperative day. The patient outcome is a strong argument on the merit of the treatment strategy.


Blood Vessel Prosthesis Implantation , Embolization, Therapeutic , Endovascular Procedures , Iliac Aneurysm/surgery , Iliac Artery/surgery , Intestinal Fistula/surgery , Sigmoid Diseases/surgery , Vascular Fistula/surgery , Aged, 80 and over , Emergencies , Humans , Iliac Aneurysm/diagnostic imaging , Iliac Aneurysm/physiopathology , Iliac Artery/diagnostic imaging , Iliac Artery/physiopathology , Intestinal Fistula/diagnostic imaging , Intestinal Fistula/physiopathology , Male , Sigmoid Diseases/diagnostic imaging , Sigmoid Diseases/physiopathology , Treatment Outcome , Vascular Fistula/diagnostic imaging , Vascular Fistula/physiopathology
8.
Wounds ; 31(11): 285-291, 2019 Nov.
Article En | MEDLINE | ID: mdl-31730510

BACKGROUND: Isolation of the enteroatmospheric fistula (EAF) opening and prevention of contamination of the rest of the wound by effluent are important factors in the management of EAF. OBJECTIVE: The aim of this study is to describe an easily reproducible technique for effluent control in patients with EAF. MATERIALS AND METHODS: A retrospective analysis was conducted on all patients who underwent the present technique between 2013 and 2015. The surgical technique included condom-EAF anastomosis, fistula ring creation, negative pressure wound therapy (NPWT), and adaptation of an ostomy bag. RESULTS: A total of 7 patients with a Björck grade 4 abdomen were included. All fistulas were located in the small bowel with a median number of 2 EAFs (range, 2-3) in each patient, and the majority had moderate output volume. The mean number of NPWT changes was 10 (range, 5-18), the mean time of NPWT use was 75.7 days (range, 60-120 days), and the mean length of stay was 108.2 days (range, 103-160 days). The mean time of ostomy formation to restitution of bowel continuity was 14.3 months (range, 8-20 months). Open anterior component separation was employed in all cases for closure of the abdominal wall. No mortality, ventral herniation, or refistulization was registered in the study. The mean follow-up time was 8.5 months (range, 6-12 months). CONCLUSIONS: This is an easily reproducible and safe technique for effluent control in patients with Björk grade 4 abdomen with established EAF.


Abdominal Cavity/surgery , Abdominal Wound Closure Techniques , Enterostomy/methods , Intestinal Fistula/surgery , Wound Healing/physiology , Adult , Aged , Colostomy/methods , Female , Humans , Intestinal Fistula/physiopathology , Male , Middle Aged , Negative-Pressure Wound Therapy , Retrospective Studies , Surgical Stomas/physiology , Suture Techniques , Treatment Outcome
9.
Surg Clin North Am ; 99(6): 1151-1162, 2019 Dec.
Article En | MEDLINE | ID: mdl-31676054

Medical treatment remains the mainstay of perianal disease management for CD; however, aggressive surgical management should be considered for severe or recurrent disease. In all cases of perianal CD, medical and surgical treatments should be used in tandem by a multidisciplinary team. Significant development has been made in the treatment of Crohn's-related fistulas, particularly minimally invasive options with recent clinical trials showing success with mesenchymal stem cell applications. Inevitably, some patients with severe refractory disease may require fecal diversion or proctectomy. When considering reversal of a diverting or end ileostomy, cessation of proctitis is the most important factor.


Crohn Disease/therapy , Intestinal Fistula/surgery , Rectal Diseases/therapy , Combined Modality Therapy , Crohn Disease/complications , Crohn Disease/diagnosis , Female , Humans , Intestinal Fistula/etiology , Intestinal Fistula/physiopathology , Male , Proctectomy/adverse effects , Proctectomy/methods , Prognosis , Rectal Diseases/diagnosis , Rectal Diseases/etiology , Risk Assessment , Severity of Illness Index , Treatment Outcome
10.
Eur J Gastroenterol Hepatol ; 31(11): 1361-1369, 2019 Nov.
Article En | MEDLINE | ID: mdl-31567640

BACKGROUND: Disease phenotype and outcome of late-onset Crohn's disease are still poorly defined. METHODS: In this Italian nationwide multicentre retrospective study, patients diagnosed ≥65 years (late-onset) were compared with young adult-onset with 16-39 years and adult-onset Crohn's disease 40-64 years. Data were collected for 3 years following diagnosis. RESULTS: A total of 631 patients (late-onset 153, adult-onset 161, young adult-onset 317) were included. Colonic disease was more frequent in late-onset (P < 0005), stenosing behaviour was more frequent than in adult-onset (P < 0003), but fistulising disease was uncommon. Surgery rates were not different between the three age groups. Systemic steroids were prescribed more frequently in young adult-onset in the first year, but low bioavailability steroids were used more frequently in late-onset in the first 2 years after diagnosis (P < 0.036, P < 0.041, respectively). The use of immunomodulators and anti-TNF's even in patients with more complicated disease, that is, B2 or B3 behaviour (Montreal classification), remained significantly inferior (P < 0.0001) in late-onset compared to young adult-onset. Age at diagnosis, Charlson comorbidity index, and steroid used in the first year were negatively associated with the use of immunomodulators and biologics. Comorbidities, related medications and hospitalizations were more frequent in late-onset. Polypharmacy was present in 56% of elderly Crohn's disease patients. CONCLUSION: Thirty-two percent of late-onset Crohn's disease presented with complicated disease behaviour. Despite a comparable use of steroids and surgery, immunomodulators and biologics were used in a small number of patients.


Colitis/physiopathology , Crohn Disease/physiopathology , Ileitis/physiopathology , Intestinal Fistula/physiopathology , Adolescent , Adult , Aged , Cohort Studies , Colorectal Neoplasms/epidemiology , Constriction, Pathologic/physiopathology , Crohn Disease/therapy , Digestive System Surgical Procedures/statistics & numerical data , Female , Glucocorticoids/therapeutic use , Humans , Immunologic Factors/therapeutic use , Italy , Late Onset Disorders , Male , Middle Aged , Polypharmacy , Retrospective Studies , Tumor Necrosis Factor Inhibitors/therapeutic use , Young Adult
11.
Eur J Radiol ; 118: 264-270, 2019 Sep.
Article En | MEDLINE | ID: mdl-31439253

PURPOSE: A multiphasic cine sequence performed during magnetic resonance enterography (MRE) has been shown to increase diagnostic accuracy of MRE demonstrating limited movement in inflamed intestine in patients with Crohn's disease (CD). Our aim was to confirm in our study population that intestinal inflammation was associated with decreased motility and determine if factors suggestive of complicated disease such as the presence of a stricture or fistula were associated with decreased motility on the MRE cine sequence. METHODS: This was a retrospective study of 59 patients (mean age 40.8 ±â€¯16.1) with Crohn's disease who had a small bowel lesion on MRE. Two gastrointestinal radiologists independently scored MRE findings using a qualitative, subjective scoring system. Univariate and multivariable ordered logistic regression models were used to evaluate the associations between cine sequence score, radiologic image findings, and clinical data. RESULTS: On univariate analysis, radiologic findings reflecting active inflammation, the presence of a stricture, and penetrating disease were associated with decreased motility. On multivariable analysis, hyper-enhancement, the presence of a comb sign, and global evidence of active inflammation remained associated with decreased motility. Of the factors suggesting complicated disease, the presence of stricture (Odds Ratio 0.40, 95% Confidence Interval 0.17-0.95, p-value 0.038) was associated with decreased motility. CONCLUSIONS: As previously shown, well-established radiologic findings of bowel inflammation were associated with decreased small bowel motility. In this study, we have added that the radiologic finding of a fixed stricture is also associated with decreased motility.


Crohn Disease/physiopathology , Gastrointestinal Motility/physiology , Intestine, Small , Adult , Aged , Constriction, Pathologic/pathology , Constriction, Pathologic/physiopathology , Crohn Disease/pathology , Cutaneous Fistula/etiology , Cutaneous Fistula/pathology , Cutaneous Fistula/physiopathology , Female , Humans , Inflammation/pathology , Intestinal Fistula/etiology , Intestinal Fistula/pathology , Intestinal Fistula/physiopathology , Intestinal Obstruction/pathology , Intestines/pathology , Logistic Models , Magnetic Resonance Imaging/methods , Magnetic Resonance Imaging, Cine/methods , Male , Middle Aged , Retrospective Studies , Young Adult
12.
Wound Manag Prev ; 65(7): 36-40, 2019 07.
Article En | MEDLINE | ID: mdl-31373562

Although Crohn's Disease (CD) usually occurs between the second and third decade of life, it also may develop in older adults. Treating elderly patients may be challenging due to other comorbidities, including diverticular disease or intestinal ischemia. PURPOSE: The purpose of this case study was to describe successful treatment of atypical and life-threatening CD due to enterocutaneous fistulas with short-bowel syndrome and multiorgan failure after partial colectomy. CASE REPORT: After an urgent colectomy for an inflammatory colon tumor, a 64-year-old woman with a history of CD and multiple comorbidities developed acute small bowel ischemia. Following an extended bowel resection, she developed a severe surgical site infection, entero- and gastrocutaneous fistulas, multiorgan failure, and short bowel syndrome. Her care included intensive medical and nutritional treatment as well as negative pressure wound therapy (NPWT) using continuous negative pressure of -80 mm Hg. She not only survived, but she also achieved complete wound closure and restoration of digestive tract continuity and metabolic control. She was discharged with a central venous catheter on total parenteral nutrition. CONCLUSION: In this case study, a good outcome was observed using intensive medical treatment, nutritional therapy, and conservative surgical treatment that included NPWT for a patient with CD and major comorbidities who developed postoperative complications.


Colectomy/adverse effects , Crohn Disease/complications , Colectomy/methods , Female , Humans , Intestinal Fistula/etiology , Intestinal Fistula/physiopathology , Middle Aged , Surgical Wound Infection/etiology , Surgical Wound Infection/physiopathology
13.
J Wound Ostomy Continence Nurs ; 46(4): 337-342, 2019.
Article En | MEDLINE | ID: mdl-31274868

BACKGROUND: Repair of an enterocutaneous fistula (ECF) is challenging, particularly when complications occur. This case describes the use of negative pressure wound therapy (NPWT) and microadhesive dressings with polyabsorbent fibers and an acrylic core, with and without lipidocolloid and nano-oligosaccharide factors, in the management of a patient with a large abdominal wound and ECF. CASE: An 84-year-old woman underwent abdominoperineal resection with colostomy, hysterectomy, and subsequent chemotherapy and radiotherapy for colorectal cancer. She experienced complications, ultimately resulting in ECF of the jejunum. Initial management with NPWT was used to promote abdominal wound healing, while protecting exposed bowel loops proved challenging because of leakage of stoma effluent that impeded the formation of granulation tissue. In order to promote wound healing and prevent infection, we applied a microadhesive dressing composed of polyabsorbent fibers with an acrylic core and lipidocolloid and nano-oligosaccharide factors that facilitated autolytic debridement and healing. CONCLUSIONS: Use of NPWT with the microadhesive dressing proved successful in the management of this complex and challenging ECF.


Abdominal Wall/surgery , Intestinal Fistula/surgery , Abdominal Wall/abnormalities , Abdominal Wall/physiopathology , Abdominal Wound Closure Techniques , Aged, 80 and over , Bandages/adverse effects , Bandages/trends , Colorectal Neoplasms/complications , Colorectal Neoplasms/surgery , Female , Humans , Intestinal Fistula/physiopathology , Negative-Pressure Wound Therapy/methods , Wound Healing/drug effects , Wound Healing/physiology
15.
Med Sci Monit ; 25: 2591-2598, 2019 Apr 09.
Article En | MEDLINE | ID: mdl-30964125

BACKGROUND Prevalence and associated risk factors for pressure ulcers (PU) vary in different body areas and diseases. Few studies have focused on PU in patients with enterocutaneous fistula (ECF). The aim of the present study was to investigate the prevalence and risk factors for PU in patients with ECF. MATERIAL AND METHODS From January 2016 to June 2016, medical records of 140 patients with ECF who were transferred to the Enterocutaneous Fistula Treatment Center, Jinling Hospital, were reviewed and analyzed. The prevalence of PU was investigated. To evaluate the risk factors for PU in patients with ECF, 5 patients with PU before admission were excluded, and the remaining 135 patients were divided into 2 groups: the PU group and the non-PU group. The risk factors for PU were confirmed by multivariate logistic regression analysis of characteristics on admission. RESULTS There were 42 cases with PU (5 cases with PU before admission, 37 cases with PU in the treatment after admission), and the prevalence of PU in patients with ECF was 30%. In addition, Braden risk score <19 (OR=9.33, CI: 2.80-31.08, p<0.001); underweight (BMI<18.5) (OR=5.21, CI: 1.65-16.39, p=0.005); onset of duodenal fistula (OR=4.86, CI: 1.33-17.78, p=0.017); diabetes (OR=4.95, CI: 1.03-23.85, p=0.046); and APACHE II score (OR=1.34, CI: 1.04-1.72, p=0.019) were associated with PU. CONCLUSIONS The PU prevalence was 30% in patients with ECF. Braden risk score <19, underweight, onset of duodenal fistula, diabetes, and APACHE II score were risk factors for PU in patients with ECF.


Intestinal Fistula/complications , Intestinal Fistula/physiopathology , Pressure Ulcer/etiology , Adolescent , Adult , Aged , Asian People/genetics , China , Female , Humans , Male , Middle Aged , Prevalence , Retrospective Studies , Risk Factors
16.
Medicine (Baltimore) ; 98(10): e14653, 2019 Mar.
Article En | MEDLINE | ID: mdl-30855454

RATIONALE: Currently, fistucolysis helps to establish intestinal nutrition and succus entericus reinfusion in the case of controllable mature high-output enterocutaneous fistula. However, if the tube cannot reach the distal limb of a fistula, fistuloclysis is not achieved. We proposed a strategy to establish succus entericus reinfusion for intractable intestinal fistula through percutaneous enterostomy. PATIENT CONCERNS: A 43-year-old man was transferred to our facility for postoperative enterocutaneous fistulae, sepsis, malnutrition, and electrolyte and fluid imbalance. The contrast X-ray demonstrated the breakdown of the primary anastomosis, with fistula output ranging from 1500 to 2000 mL/d, despite the administration of medications to reduce gastrointestinal secretions. DIAGNOSES: The patient was diagnosed with high-output anastomosis fistula by gastrointestinal radiography. INTERVENTIONS: We used percutaneous enterostomy to establish fistuloclysis. OUTCOMES: Fistuloclysis was established by percutaneous enterostomy successfully. No complications were found during the past 4-month follow-up after percutaneous enterostomy. He is waiting for reconstruction surgery after 6 months' enteral nutrition (EN). LESSONS: Fistuloclysis-assisted EN, if used appropriately, avoids the complications of long-term parenteral nutrition (PN) and may promote faster fistula healing.


Enteral Nutrition/methods , Enterostomy/methods , Fluid Therapy/methods , Intestinal Fistula , Postoperative Complications/therapy , Sepsis , Water-Electrolyte Imbalance , Adult , Humans , Intestinal Fistula/diagnosis , Intestinal Fistula/etiology , Intestinal Fistula/physiopathology , Intestinal Fistula/surgery , Intestines/diagnostic imaging , Intestines/physiopathology , Male , Nutritional Status , Radiography, Abdominal/methods , Sepsis/etiology , Sepsis/therapy , Surgical Stomas , Treatment Outcome , Water-Electrolyte Imbalance/etiology , Water-Electrolyte Imbalance/therapy
17.
Pol Przegl Chir ; 91(1): 35-37, 2019 Jan 03.
Article En | MEDLINE | ID: mdl-30919818

Abdominal tuberculosis is a common problem for clinicians in the tropical world and may manifest with varying clinical scenarios. Intestinal tuberculosis could have intestinal ulcers, strictures, hypertrophic lesions like polyps and may be complicated by perforation, bleeding, and intestinal obstruction. Crohn's disease is an important differential of intestinal tuberculosis which is closely mimics intestinal tuberculosis in clinical, endoscopic, radiological and histological presentation. Crohn's disease is known to have a fistulising variant. We report the case of 23 year old lady who had disseminated tuberculosis with intestinal involvement and seemed to improve on anti-tubercular therapy (ATT) but present with intestinal obstruction in the third month of ATT. Surgical exploration revealed clumping of bowel loops with multiple ileo-ileal fistulae. The case is presented because of the presence of entero-enteric fistulae and also because it demonstrated that intestinal tuberculosis may need surgical intervention even after initial improvement because of complications like intestinal obstruction.


Crohn Disease/diagnosis , Crohn Disease/physiopathology , Intestinal Fistula/complications , Intestinal Fistula/surgery , Tuberculosis, Gastrointestinal/diagnosis , Tuberculosis, Gastrointestinal/surgery , Adult , Diagnosis, Differential , Female , Humans , Intestinal Fistula/physiopathology , Treatment Outcome , Tuberculosis, Gastrointestinal/physiopathology , Young Adult
18.
Ann Vasc Surg ; 59: 310.e1-310.e5, 2019 Aug.
Article En | MEDLINE | ID: mdl-30802570

The treatment of recurrent aortoenteric fistula (AEF) previously repaired by surgery is challenging, with a high mortality rate. Open repair is often limited by "hostile abdomen," while endovascular treatment is difficult when the distance between the aortic stump and the origin of the renal arteries is short, with high risk of their occlusion. We describe a recurrent AEF repaired by surgery 4 months earlier, treated by endovascular coiling of the aortic stump after deployment of 2 renal artery stent grafts with the chimney technique.


Aortic Diseases/therapy , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis , Duodenal Diseases/therapy , Embolization, Therapeutic/instrumentation , Endovascular Procedures/instrumentation , Intestinal Fistula/therapy , Renal Artery/surgery , Stents , Vascular Fistula/therapy , Aged , Aortic Diseases/diagnostic imaging , Aortic Diseases/physiopathology , Aortography/methods , Blood Vessel Prosthesis Implantation/methods , Computed Tomography Angiography , Duodenal Diseases/diagnostic imaging , Duodenal Diseases/physiopathology , Endovascular Procedures/methods , Fatal Outcome , Humans , Intestinal Fistula/diagnostic imaging , Intestinal Fistula/physiopathology , Male , Prosthesis Design , Recurrence , Renal Artery/diagnostic imaging , Renal Artery/physiopathology , Reoperation , Treatment Outcome , Vascular Fistula/diagnostic imaging , Vascular Fistula/physiopathology
19.
Clin Gastroenterol Hepatol ; 17(9): 1904-1908, 2019 08.
Article En | MEDLINE | ID: mdl-30292887

Fistulizing complications develop in approximately one third of patients with Crohn's disease (CD), resulting in morbidity and impaired quality of life.1 Sites of fistulae most commonly include perianal fistulae, but also enterocutaneous, enteroenteric, enterovesical, and rectovaginal. Its management requires combined medical and surgical strategies to prevent abscess formation and induce healing. Biologic agents have improved the medical treatment of CD-related fistulae, but many patients still require surgical intervention. Hence, there is considerable interest in the development of novel pharmaceutical agents to treat fistulizing CD.


Crohn Disease/therapy , Cutaneous Fistula/therapy , Immunosuppressive Agents/therapeutic use , Intestinal Fistula/therapy , Mesenchymal Stem Cell Transplantation , Tumor Necrosis Factor Inhibitors/therapeutic use , Urinary Fistula/therapy , Crohn Disease/physiopathology , Cutaneous Fistula/physiopathology , Female , Gastrointestinal Agents/therapeutic use , Humans , Intestinal Fistula/physiopathology , Male , Outcome Assessment, Health Care , Quality of Life , Randomized Controlled Trials as Topic , Rectal Fistula/physiopathology , Rectal Fistula/therapy , Rectovaginal Fistula/physiopathology , Rectovaginal Fistula/therapy , Treatment Outcome , Urinary Fistula/physiopathology
...